Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

BACKGROUND: In France, the combination hydroxychloroquine (HCQ) and azithromycin (AZ) is used in the treatment of COVID-19. METHODS: We retrospectively report on 1061 SARS-CoV-2 positive tested patients treated for at least three days with the following regimen: HCQ (200 mg three times daily for ten...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Travel Med Infect Dis
Glavni autori: Million, Matthieu, Lagier, Jean-Christophe, Gautret, Philippe, Colson, Philippe, Fournier, Pierre-Edouard, Amrane, Sophie, Hocquart, Marie, Mailhe, Morgane, Esteves-Vieira, Vera, Doudier, Barbara, Aubry, Camille, Correard, Florian, Giraud-Gatineau, Audrey, Roussel, Yanis, Berenger, Cyril, Cassir, Nadim, Seng, Piseth, Zandotti, Christine, Dhiver, Catherine, Ravaux, Isabelle, Tomei, Christelle, Eldin, Carole, Tissot-Dupont, Hervé, Honoré, Stéphane, Stein, Andreas, Jacquier, Alexis, Deharo, Jean-Claude, Chabrière, Eric, Levasseur, Anthony, Fenollar, Florence, Rolain, Jean-Marc, Obadia, Yolande, Brouqui, Philippe, Drancourt, Michel, La Scola, Bernard, Parola, Philippe, Raoult, Didier
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Ltd. 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7199729/
https://ncbi.nlm.nih.gov/pubmed/32387409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tmaid.2020.101738
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items